
    
      There are two parts of phase IVc clinical trials have been performed. First, to evaluate the
      immunogenicity of the inactive EV71 vaccine in large scale population of Chinese children
      (from 6 to 71 months old), within 56-day-post-immunized.

      Second, to long-term immunogenicity of the inactive EV71 vaccine in large scale population of
      Chinese children (from 6 to 71 months old).
    
  